|
?:authorAffiliation
|
-
[\'Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.\', \'ICES, Toronto, ON, Canada.\', \'Centre for Vaccine Preventable Diseases, University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada.\', \'Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.\', \'Department of Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Internal Medicine/Section General Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Hematology, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.\', \'Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Pediatric, Section of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, CT, USA.\', \'Yale Institute for Global Health, Yale University, New Haven, CT, USA.\', \'Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.\', \'Howard Hughes Medical Institute, Chevy Chase, MD, USA. akiko.iwasaki@yale.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}